ALVO
AlvotechNASDAQHealthcare$3.65+0.83%ClosedMarket Cap: $1.14B
As of 2026-04-06
Valuation
P/E (TTM)
40.74
PEG
0.36
P/B
-3.58
P/S
1.94
EV/EBITDA
30.87
DCF Value
$-349.09
FCF Yield
-10.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.8%
Operating Margin
13.3%
Net Margin
4.8%
ROE
-11.9%
ROA
2.0%
ROIC
1.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $166.4M | 63.2% | $48.2M | $-108.6M | $-0.43 | — |
| FY 2025 | $586.3M | 59.8% | $78.2M | $27.9M | $0.10 | — |
| Q3 2025 | $114.0M | 69.3% | $1.4M | $-5.2M | $-0.02 | — |
| Q2 2025 | $173.2M | 57.4% | $18.1M | $32.0M | $0.10 | — |
| Q1 2025 | $132.8M | 50.7% | $10.6M | $109.7M | $0.35 | — |
| Q4 2024 | $151.2M | 46.9% | $13.5M | $-67.0M | $-0.22 | — |
| FY 2024 | $489.7M | 62.2% | $69.6M | $-231.9M | $-0.87 | — |
| Q3 2024 | $102.9M | 61.3% | $12.7M | $-11.4M | $-0.04 | — |
| Q2 2024 | $198.8M | 77.3% | $91.9M | $65.2M | $0.25 | — |
| Q1 2024 | $36.9M | 45.8% | $-48.4M | $-218.7M | $-0.82 | — |
| Q4 2023 | $53.4M | -5.7% | $-79.0M | $-276.6M | $-1.04 | — |
| FY 2023 | $91.4M | -75.9% | $-354.9M | $-551.7M | $-2.43 | — |